)
Edge31 Oct 2025
Rolls-Royce: Full Thrust Ahead
From century-old crafted perfection to pandemic shock and reset, Rolls-Royce's story is shaped by heritage, turbulence, and a disciplined climb back.
Cardiol Therapeutics (CRDL) investor relations material
Cardiol Therapeutics SEO filing summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.SEO filing summary5 Nov, 2025
Company overview and business model
Clinical-stage life sciences company focused on anti-inflammatory and anti-fibrotic therapies for heart diseases, with lead candidate CardiolRx (cannabidiol) in clinical development for recurrent pericarditis and acute myocarditis.
CardiolRx targets inflammasome pathway, implicated in inflammation and fibrosis in myocarditis, pericarditis, and heart failure.
Received FDA Orphan Drug Designation for pericarditis; planning to pursue similar designation for acute myocarditis.
Developing a novel subcutaneous cannabidiol formulation for heart failure, addressing a market with over $30 billion in annual US healthcare costs.
Financial performance and metrics
As of March 31, 2024: cash and cash equivalents of $28.6M, share capital of $151.1M, contributed surplus of $17.2M, and a deficit of $151.8M, with total capitalization at $20.1M.
Negative operating cash flow in recent years; ongoing need to fund negative cash flow from operations.
Use of proceeds and capital allocation
Net proceeds will be used for business objectives, general corporate purposes, working capital, debt repayment, capital programs, and potential acquisitions.
Key milestones: complete Phase II MAVERIC-Pilot study (H2 2024, $500K), Phase III pericarditis study (TBD, $20M), complete Phase II ARCHER trial (H1 2025, $5M), initiate Phase III ARCHER trial (TBD, $10M), and advance CRD-38 program.
Estimated $2–2.5M per quarter in general and administrative costs, with sufficient resources for near-term milestones.
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Cardiol Therapeutics earnings date
Q3 202519 Nov, 2025
Next Cardiol Therapeutics earnings date
Q3 202519 Nov, 2025
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Cardiol Therapeutics Inc. is a biopharmaceutical company focused on developing anti-inflammatory and anti-fibrotic therapies for cardiovascular diseases. The company specializes in small molecule therapeutics targeting conditions such as acute myocarditis, heart failure, and other inflammatory heart disorders. The company is headquartered in Oakville, Ontario, Canada, and its shares are listed on the NASDAQ and TSX.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage